Home NDC 70518-2337 Olanzapine
Product NDC 70518-2337
11-digit product format 705182337
Labeler code 70518
Product ID 70518-2337_57370e01-72e8-85c6-e063-6294a90ab347
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Olanzapine
Dosage form TABLET, FILM COATED
Route ORAL
Labeler REMEDYREPACK INC.
Application ANDA202862
Marketing category ANDA
Marketing start 2019-10-02
Substance OLANZAPINE
Active strength 20 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 22 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70518-2337-0 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70518-2337-0 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70518-2337-0 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70518-2337-0 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70518-2337-0 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70518-2337-0 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70518-2337-0 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70518-2337-0 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70518-2337-0 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 70518-2337-0 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 70518-2337-0 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 70518-2337-0 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202862-001 OLANZAPINE OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 A202862-002 OLANZAPINE OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 A202862-003 OLANZAPINE OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 A202862-004 OLANZAPINE OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 A202862-005 OLANZAPINE OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 A202862-006 OLANZAPINE OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-005 OLANZAPINE 15MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202862-006 OLANZAPINE 20MG TABLET / ORAL AB 2014-08-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202862-001 OLANZAPINE 2.5MG TABLET / ORAL AB 2014-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202862-002 OLANZAPINE 5MG TABLET / ORAL AB 2014-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202862-003 OLANZAPINE 7.5MG TABLET / ORAL AB 2014-08-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202862-004 OLANZAPINE 10MG TABLET / ORAL AB 2014-08-15 b8a1b40f171c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 258 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Olanzapine
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OLANZAPINE 20 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination N7U69T4SZR Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 283639 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-2337-0 Olanzapine 30 in 1 BLISTER PACK TABLET, FILM COATED 30 9 70518-2337-1 Olanzapine 30 in 1 BLISTER PACK TABLET, FILM COATED 30 9
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 23 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 70518-2337-0 70518233700 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2337-0) 2019-10-02 0000-00-00 No No Current 70518-2337-1 70518233701 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2337-1) 2025-08-06 No No Current